Alphagen Securities »

Provectus Biopharmaceuticals I shares owned by Alphagen Securities

Quarter-by-quarter ownership of Provectus Biopharmaceuticals I (PVCT) shares owned by Alphagen Securities from 13F filings

Historical chart of Alphagen Securities investment in Provectus Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Provectus Biopharmaceuticals I held by Alphagen Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Provectus Biopharmaceuticals I by Alphagen Securities

Quarter filed Position value Share count Share price at filing
2015-09-30 $2.0k 3.7k 0.54
2015-06-30 $2.0k 3.1k 0.65
2015-03-31 $1.0k 800 1.25
2014-12-31 $640 800 0.80

More positions owned by Alphagen Securities

Baker Hughes Incorporated
Apple (AAPL)
HCC Insurance Holdings
Unilever (UL)
Williams Partners
priceline.com Incorporated
Pepco Holdings
Netflix (NFLX)
CBOE Holdings (CBOE)
Mylan Nv
Altera Corporation
Amazon (AMZN)
Williams Companies (WMB)
CenturyLink
International Business Machines (IBM)

View all positions for Alphagen Securities

Top funds holding Provectus Biopharmaceuticals I

Home Federal Bank Of Tennessee
Lee, Danner & Bass
Atlas Wealth
LBMC Investment Advisors
Academy Capital Management
Financial Symmetry
Huntington National Bank

View all funds holding Provectus Biopharmaceuticals I